Junli He - 10 Apr 2023 Form 4/A - Amendment Insider Report for Biostage, Inc. (HRGN)

Role: CEO, Director
Signature: /s/ Joseph Damasio, by power of attorney
Issuer symbol: HRGN
Transactions as of: 10 Apr 2023
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 10 Jul 2023, 15:47:44 UTC
Date Of Original Report: 12 Apr 2023
Previous filing: 05 Jan 2023
Next filing: 28 Aug 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSTG	Stock Option (right to buy)	Award	$0	+267,616		$0.000000	267,616	10 Apr 2023	Common Stock, par value $0.01 per share	267,616	$6.08	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On April 12, 2023, the Reporting Person filed a Form 4 (the "Original Form 4"), which noted a stock option (right to buy) of 488,256 shares (also known as milestone options) of Biostage, Inc. On July 10, 2023, the Issuer and Reporting Person amended and corrected such option amount to 267,616 shares. This amendment is being filed to amend and restate the reporting of those stock options to report the corrected amount. Subject to continued employment or service through the applicable vesting dates, up to 267,616 shall vest in two increments, each for 133,808 shares, each such vesting subject to certain performance milestones set by the Board of Directors of the Issuer.

Content

On April 12, 2023, the Reporting Person filed a Form 4 (the "Original Form 4"), which noted a stock option (right to buy) of 488,256 shares (also known as milestone options) of Biostage, Inc. On July 10, 2023, the Issuer and Reporting Person amended and corrected such option amount to 267,616 shares. This amendment is being filed to amend and restate the reporting of those stock options to report the corrected amount. Subject to continued employment or service through the applicable vesting dates, up to 267,616 shall vest in two increments, each for 133,808 shares, each such vesting subject to certain performance milestones set by the Board of Directors of the Issuer.